| Returns | 1W : -1.1% , 1M : 0.1%,1Y : -13.4% | www.lupin.com |
| LT : |
Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : High |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| LUPIN | -1.1% | 0.1% | -13.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -0.3% | 47.1% |
| DIVIS LABORATORIES | 1.7% | 7.3% | 53.8% |
| DR REDDYS LABORATORIES | -1.9% | 4.5% | -9% |
| CIPLA | 1.5% | 5.5% | 19.6% |
| GLAND PHARMA | -1.6% | 2.6% | NA |
| PIRAMAL ENTERPRISES | 5.6% | 6.6% | 95.6% |
| CADILA HEALTHCARE | 1.6% | 3.3% | 37.2% |
| TORRENT PHARMACEUTICALS | 0.2% | 1.5% | 7.4% |
| Ratio | Consolidated |
|---|---|
|
P/E P/B P/S |
34.55
P/E Calculated based on EPS of 26.81
[ Mar2021 - Consolidated Results ] 3.09
P/B Calculated based on Book Value of 300.06
[ Mar2021 - Consolidated Results ] 2.64
P/S Calculated based on Revenues of 15905.7 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
15% -10% -12% |
| Pledged Shares |
0 % |
|---|---|
| As on : Jun2021 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE MOMENTUM | 2.8% | 7.2% | 41.8% |
| S&P BSE LARGECAP | 2.5% | 7.3% | 54.6% |
| S&P BSE LARGE MIDCAP | 2.5% | 7.6% | 56.6% |
| S&P BSE 100 | 2.5% | 7.4% | 55.5% |
| S&P BSE CARBONEX | 2.5% | 7.2% | 54.9% |
| S&P BSE 250 LARGEMIDCAP | 2.5% | 7.6% | 57.8% |
| S&P BSE 200 | 2.5% | 7.6% | 57.5% |
| S&P BSE 100 LARGECAP TMC | 2.5% | 7.4% | 55.3% |
| S&P BSE 500 | 2.5% | 7.7% | 59.1% |
| S&P BSE ALLCAP | 2.4% | 7.7% | 60.1% |
| S&P BSE GREENEX | 2.4% | 6.9% | 56% |
| S&P BSE 100 ESG INDEX | 2.1% | 6.5% | 54.7% |
| S&P BSE SENSEX NEXT 50 | 2.1% | 8.9% | 59.4% |
| S&P BSE QUALITY | 1.2% | 5.1% | 47.8% |
| S&P BSE HEALTHCARE | 0.4% | 1.9% | 30.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 200 | 2.5% | 7.8% | 57.6% |
| NIFTY LARGE MIDCAP 250 | 2.5% | 8.3% | 63.2% |
| NIFTY 100 | 2.5% | 7.5% | 55.4% |
| NIFTY 500 | 2.5% | 7.8% | 59.1% |
| NIFTY500 MULTICAP 50:25:25 | 2.4% | 8.1% | NA |
| NIFTY 100 EQUAL WEIGHT | 2.2% | 7.9% | 63.1% |
| NIFTY 100 ALPHA 30 | 1.8% | 6.6% | NA |
| NIFTY NEXT 50 | 1.7% | 8.3% | 57.7% |
| NIFTY PHARMA | 1.4% | 3.3% | 16.7% |
| NIFTY HEALTHCARE | 0.6% | 1.5% | NA |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure